Elite in Swallowing Difficulty

Dr. David A. Katzka

Gastroenterology
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Elite in Swallowing Difficulty
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Katzka is a Gastroenterologist in New York, New York. Dr. Katzka is rated as an Elite provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Esophagitis, Eosinophilic Esophagitis, Barrett Esophagus, Endoscopy, and Gastrectomy.

His clinical research consists of co-authoring 363 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Swallowing Difficulty.

Specialties
Gastroenterology
Licenses
Internal Medicine in PA
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Northwell Health
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
622 W 168th St, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
Enrollment Status: Recruiting
Publish Date: September 12, 2025
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Protocol for Food Antigen Staining in Esophageal Mucosa in Patients With Eosinophilic Esophagitis
Protocol for Food Antigen Staining in Esophageal Mucosa in Patients With Eosinophilic Esophagitis
Enrollment Status: Completed
Publish Date: December 12, 2023
Intervention Type: Other
The Association Between Nitrates, Nitrosylated Proteins, and Interleukin-8 in Barrett's Esophagus and Esophageal Adenocarcinoma
The Association Between Nitrates, Nitrosylated Proteins, and Interleukin-8 in Barrett's Esophagus and Esophageal Adenocarcinoma
Enrollment Status: Terminated
Publish Date: December 15, 2022
Cytosponge Protocol
Cytosponge Protocol
Enrollment Status: Terminated
Publish Date: June 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
Assessment of Fibrotic and Inflammatory Components by MRI in Strictures Associated With Eosinophilic Esophagitis Before and After Treatment
Assessment of Fibrotic and Inflammatory Components by MRI in Strictures Associated With Eosinophilic Esophagitis Before and After Treatment
Enrollment Status: Terminated
Publish Date: February 28, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

363 Total Publications

Dermatologic Conditions That Can Involve the Esophagus.
Dermatologic Conditions That Can Involve the Esophagus.
Journal: Gastroenterology & hepatology
Published: May 26, 2025
Similar Doctors
Elite in Swallowing Difficulty
Dr. Daniela Jodorkovsky
Gastroenterology
Elite in Swallowing Difficulty
Dr. Daniela Jodorkovsky
Gastroenterology

Icahn School Of Medicine At Mount Sinai

425 W 59th St, 
New York, NY 
 (5.4 miles away)
212-961-5500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniela Jodorkovsky is a Gastroenterologist in New York, New York. Dr. Jodorkovsky is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. Her top areas of expertise are Gastroesophageal Reflux Disease (GERD), Swallowing Difficulty, Achalasia, Endoscopy, and Gastrectomy.

Distinguished in Swallowing Difficulty
Dr. Amir E. Masoud
Gastroenterology
Distinguished in Swallowing Difficulty
Dr. Amir E. Masoud
Gastroenterology

Hartford Healthcare Medical Group Specialists PLLC

425 Post Rd, 
Fairfield, CT 
 (42.2 miles away)
203-254-2452
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Amir Masoud is a Gastroenterologist in Fairfield, Connecticut. Dr. Masoud is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Swallowing Difficulty, Gastroesophageal Reflux Disease (GERD), Achalasia, Endoscopy, and Gastrectomy.

Distinguished in Swallowing Difficulty
Dr. Chintan Modi
Gastroenterology
Distinguished in Swallowing Difficulty
Dr. Chintan Modi
Gastroenterology

Hackensack Meridian Health Medical Group - Specialty Care PC

530 New Brunswick Ave, 
Perth Amboy, NJ 
 (28.5 miles away)
848-309-1436
Languages Spoken:
English
See accepted insurances

Chintan Modi is a Gastroenterologist in Perth Amboy, New Jersey. Dr. Modi is rated as a Distinguished provider by MediFind in the treatment of Swallowing Difficulty. His top areas of expertise are Gastric Dysmotility, Chronic Idiopathic Constipation (CIC), Painful Swallowing, Gastrostomy, and Colonoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Katzka's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 7 Distinguished Conditions
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile